Loading clinical trials...
Loading clinical trials...
A U.S. Registry of Eosinophilic Esophagitis Patients Treated With DUPIXENT® As Standard of Care
This observational research study is to better understand patients with eosinophilic esophagitis (EoE) who have recently been prescribed DUPIXENT® (dupilumab). The purpose of this research study is to look at how DUPIXENT is used in normal care of patients with EoE. Possible benefits to others include a better understanding of EoE and helping to inform research and clinical trial design leading to treatment decisions in this patient population going forward. Patient questionnaires will measure the following: * How EoE makes one feel * EoE signs and/or symptoms, eg, how difficult it is to swallow * How EoE affects quality-of-life * How EoE impacts aspects of daily life * How EoE symptoms have changed throughout the study
Age
1 - No limit years
Sex
ALL
Healthy Volunteers
No
Phoenix Childrens Hospital
Phoenix, Arizona, United States
Arizona Digestive Health/GI Alliance
Sun City, Arizona, United States
Arkansas Childrens Hospital
Little Rock, Arkansas, United States
Scripps Clinic
La Jolla, California, United States
University of California Los Angeles (UCLA)
Los Angeles, California, United States
University of Southern California Keck School of Medicine
Los Angeles, California, United States
University of California, San Francisco
Oakland, California, United States
University of California San Francisco (UCSF)
San Francisco, California, United States
Childrens Hospital Colorado
Aurora, Colorado, United States
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Start Date
November 22, 2024
Primary Completion Date
May 22, 2030
Completion Date
May 22, 2030
Last Updated
March 20, 2026
350
ESTIMATED participants
dupilumab
DRUG
Lead Sponsor
Regeneron Pharmaceuticals
Collaborators
NCT06389994
NCT04394351
NCT03581838
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions